focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Feb 2012 07:00

RNS Number : 3407X
Spectra Systems Corporation
14 February 2012
 



For immediate release

14 February 2012

 

 

Spectra Systems Corporation

 

("Spectra" or the "Company")

Appointment of Non-Executive Director

Spectra, a leading provider of advanced technology solutions for banknote and product authentication, is pleased to announce that on 13 February 2012 Jeffrey Donohue joined the Company as a Non-Executive director, replacing Mark Curcio, whose resignation as a Non-Executive director was announced on 10 February 2012.

Jeffrey Peter Donohue (aged 40) is Corporate Counsel for Novartis Institutes for BioMedical Research, Inc. ("NIBRI"), the research arm of the global healthcare products company Novartis. Mr. Donohue provides legal guidance on NIBRI's strategic acquisitions, licensing agreements, academic and government-backed consortia, and drug discovery collaborations. Mr. Donohue also is an Adjunct Professor at Boston University School of Law, USA, where he teaches advanced courses on licensing and intellectual property transactions.

 

Before joining NIBRI, Mr. Donohue served as Corporate Counsel at Vertex Pharmaceuticals Incorporated, a pharmaceutical company based in Cambridge, Massachusetts, USA. Mr. Donohue started his legal career at Kirkpatrick & Lockhart LLP (now K&L Gates), where he spent seven years advising clients on corporate governance, mergers and acquisitions, and securities matters. Mr. Donohue obtained his Juris Doctor from Boston University and a B.A. from Brandeis University.

Mr. Donohue was also a director of Raise The Sky Inc., from March 2009 until August 2010. There is no further information that is required to be disclosed in relation to Mr. Donohue pursuant to Schedule 2(g) of the AIM Rules for Companies.

Commenting on the appointment, Dr. Nabil Lawandy, Chief Executive of Spectra, said: "Jeff is a timely addition to the Spectra Board of Directors as we explore potential acquisitions and implement the next phase of our growth strategy."

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

 

WH Ireland Limited

Chris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

Media Enquires:

The Communications Portfolio Limited

Ariane Comstive / Caolan Mahon Tel: +44 (0) 20 7536 2028 / 2029

ariane.comstive@communications-portfolio.co.uk

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASFFFWDFESEFE
Date   Source Headline
19th Dec 20088:00 amRNSNet Asset Value(s)
18th Dec 20087:49 amRNSNet Asset Value(s)
17th Dec 20087:42 amRNSNet Asset Value(s)
16th Dec 20087:37 amRNSNet Asset Value(s)
15th Dec 20087:38 amRNSNet Asset Value(s)
12th Dec 20087:36 amRNSNet Asset Value(s)
11th Dec 20087:41 amRNSNet Asset Value(s)
10th Dec 20087:38 amRNSNet Asset Value(s)
9th Dec 20087:40 amRNSNet Asset Value(s)
8th Dec 20087:59 amRNSNet Asset Value(s)
5th Dec 20087:39 amRNSNet Asset Value(s)
4th Dec 20087:33 amRNSNet Asset Value(s)
3rd Dec 20087:43 amRNSNet Asset Value(s)
2nd Dec 20088:33 amRNSNet Asset Value(s)
1st Dec 20089:00 amRNSNet Asset Value(s)
27th Nov 20087:56 amRNSNet Asset Value(s)
26th Nov 20087:46 amRNSNet Asset Value(s)
25th Nov 20088:22 amRNSNet Asset Value(s)
24th Nov 20088:16 amRNSNet Asset Value(s)
21st Nov 20087:40 amRNSNet Asset Value(s)
20th Nov 20087:41 amRNSNet Asset Value(s)
19th Nov 20087:37 amRNSNet Asset Value(s)
18th Nov 20087:42 amRNSNet Asset Value(s)
17th Nov 20088:21 amRNSNet Asset Value(s)
14th Nov 20087:58 amRNSNet Asset Value(s)
13th Nov 20087:53 amRNSNet Asset Value(s)
12th Nov 20088:01 amRNSNet Asset Value(s)
11th Nov 20087:59 amRNSNet Asset Value(s)
10th Nov 20088:08 amRNSNet Asset Value(s)
7th Nov 20087:42 amRNSNet Asset Value(s)
6th Nov 20087:50 amRNSNet Asset Value(s)
5th Nov 20087:51 amRNSNet Asset Value(s)
4th Nov 20088:03 amRNSNet Asset Value(s)
3rd Nov 20088:20 amRNSNet Asset Value(s)
31st Oct 20087:59 amRNSNet Asset Value(s)
30th Oct 20088:09 amRNSNet Asset Value(s)
29th Oct 20087:38 amRNSNet Asset Value(s)
28th Oct 20087:55 amRNSNet Asset Value(s)
27th Oct 20087:35 amRNSNet Asset Value(s)
24th Oct 20087:20 amRNSNet Asset Value(s)
23rd Oct 20087:35 amRNSNet Asset Value(s)
22nd Oct 20087:38 amRNSNet Asset Value(s)
21st Oct 20088:05 amRNSNet Asset Value(s)
20th Oct 20087:39 amRNSNet Asset Value(s)
17th Oct 20087:25 amRNSNet Asset Value(s)
16th Oct 20087:52 amRNSNet Asset Value(s)
15th Oct 20089:50 amRNSNet Asset Value(s)
14th Oct 20087:46 amRNSNet Asset Value(s)
13th Oct 20088:18 amRNSNet Asset Value(s)
10th Oct 20087:24 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.